Professional Documents
Culture Documents
Lecture 2 - Allocation
Lecture 2 - Allocation
ALLOCATION
HAD 5303
INTERVENTIONS
TIDieR CHECKLIST
COMPONENTS OF TIDieR (1)
COMPONENTS OF TIDieR (2)
BLINDING
…enormous ambiguity in the conventional ways of describing
blinding.
BMJ. 2005;37:557
IMPLICATIONS OF BEING UNMASKED
Clinicians
• Differentially administer powerful treatments other than those under study
• Influence compliance with study drugs or willingness to continue in the study
• Influence reporting of symptoms
Data Collectors
• Vary intensity of examination or likelihood of repeating a test with unexpected finding
• Vary recording of outcomes
• Differential encouragement during performance testing
Judicial Assessors
• Bias interpretation of marginal findings
Data analysts and authors
• Biased decisions on patient withdrawals
• Biased selection of outcomes to analyze or report
• Biased choice of time points demonstrating maximum or minimum effects
• Many other important decisions in the analysis or reporting process
ALLOCATION
ALLOCATION - OBJECTIVES
Drug X Outcome
Subjects with
Condition of interest
Placebo Outcome
OBJECTIVES
Anaesthesia. 2012;67:521
Anaesthesia. 2017;72:944
WHY RANDOMIZE?
High-Risk Low-Risk
Patient Patient
New New
Old Drug Old Drug
Drug Drug
WELL-DONE RANDOMIZED STUDY
High-Risk Low-Risk
Patient Patient
New New
Old Drug Old Drug
Drug Drug
POOR ALLOCATION CONCEALMENT
High-Risk Low-Risk
Patient Patient
New New
Old Drug Old Drug
Drug Drug
POOR ALLOCATION CONCEALMENT
JAMA 1995;273:408
Lancet. 1998;352:609
BMC Medical Research Methodology 2016;16:133
ALLOCATION - OBJECTIVES
BMJ 2012;645:e5840
BMC Medical Research Methodology 2014;14:20
ALLOCATION - OBJECTIVES
✓ Opaque envelopes
✓ sealed and numbered in sequence
§ Sealed packages with the medications
§ Randomization at central pharmacy
§ Centralized telephone or online randomization
ONLINE RANDOMIZATION SERVICES
INTERVENTIONS, BLINDING and
ALLOCATION
HAD 5303